AI-assisted international press reviewPress review

Roche's Fenebrutinib: A Revolution in MS Treatment

Roche's Fenebrutinib: a promising advance against multiple sclerosis. In the FENhance 2 study, this experimental treatment significantly reduces relapses compared to teriflunomide, while FENtrepid shows at least equivalent efficacy to OCREVUS in slowing disability progression. Full data will be unveiled at upcoming medical congresses, with a submission to regulatory authorities planned after the FENhance 1 study in 2026. These results could offer new hope to patients.

Source: Roche, published under the title "[Ad hoc announcement pursuant to Art. 53 LR] Roche’s fenebru..." - 10 November 2025

JELL-O Revives Its Iconic Molds for a Fun Thanksgiving!

The century-old classic of the American table is reinvented with JELL-O: playful and colorful molds for Thanksgiving staples, transforming Brussels sprouts, cranberry sauce, and pecan pie into gelatinous delights that bring the family together for a joyful and unexpected celebration!

Source: Kraft Heinz, published under the title "JELL-O Revives Its 125-Year-Old Iconic Thanksgiving Molds fo..." - 10 November 2025

Tyson Foods: Sales and Profit Growth Expected in 2025

Tyson Foods: Annual sales growth and adjusted revenues rise despite challenges – A food industry leader strengthening its resilience and innovation for the future!

Source: Tyson Foods, published under the title "Tyson Foods Reports Fourth Quarter and Fiscal 2025 Results" - 10 November 2025

Mechanization & Robotics

Naïo Technologies: A New Direction for Autonomous Agriculture

Naïo Technologies, a pioneer in autonomous agricultural robots, strengthens its leadership with Antoine Monville and Matthias Carriere at the helm. Their collaboration aims to combine strategic vision and agricultural expertise for sustainable growth. With over 350 robots deployed, Naïo helps reduce herbicide use and improve farm profitability while addressing sustainability and food sovereignty challenges.

Source: Naïo Technologies, published under the title "NAÏO WRITES A NEW CHAPTER IN ITS STORY AND STRENGTHENS ITS I..." - 10 November 2025

ADM and Tallgrass Launch Largest CO2 Capture Plant for Ethanol in Columbus

ADM and Tallgrass join forces for an innovative CO₂ capture and storage project, linking ADM's corn processing complex in Columbus, Nebraska, to a storage hub in Wyoming. This initiative, the largest in the world for ethanol, transports over 10 million tons of CO₂ annually via the Trailblazer pipeline, equivalent to removing 2 million vehicles from the roads. A key advancement for sustainability in agritech, demonstrating how the industry transforms emissions into sustainable environmental solutions. Local partnerships and pioneering expertise drive the future of captured carbon. Source: ADM.

Source: Adm, published under the title "ADM, Tallgrass Celebrate Opening of World’s Largest Bioethan..." - 10 November 2025

Bouygues Delivers High-Tech and Sustainable Hospital in Rabat

BYMARO is revolutionizing healthcare in Morocco: The Mohammed VI University Hospital, inaugurated by the King, combines cutting-edge care with 600 beds, 24 high-tech operating rooms, and a center of excellence for education, while reducing CO₂ emissions by 40% through solar panels and exceptional HQE certification. An achievement completed in just 24 months!

Source: Bouygues Construction, published under the title "Bouygues Construction livre le complexe hospitalo-universita..." - 10 November 2025

Decisive Progress: Giant Beams for the Tram Overpass

Major advancement in Adelaide: The 90-ton Super T beams are installed for the tram bridge at Plympton, marking a decisive step in level separation projects. This construction, featuring 52 beams over 700 meters and 24 columns, enhances safety, reduces congestion, and streamlines travel for thousands of South Australians. Supported by 6,900 m³ of concrete and a partnership of experts like CPB Contractors and Arup, it transforms key intersections along the Glenelg line. An innovation for more reliable transport and revitalized public spaces.

Source: Cimic, published under the title "Initial beams installed for Marion Road tram overpass" - 10 November 2025

Turner Unveils Emergency Operations Center in Southern California

New emergency operations center in California: a state-of-the-art 60,000 square foot complex to enhance disaster preparedness and response for events like earthquakes and wildfires. Designed by Turner Construction in partnership with Cal OES and DGS, it incorporates sustainable technologies – solar energy, battery storage, and LEED Gold certification – to ensure optimal resilience and protect over 23 million residents in Southern California, with completion expected in 2027. This strategic hub promotes enhanced coordination and decisive action in times of crisis.

Source: Hochtief, published under the title "Turner Breaks Ground on Southern California Emergency Operat..." - 10 November 2025

Recognition of Projects in Singapore for Their Excellence in Safety

Proudly recognized for excellence in safety: our Singaporean projects TR308 (Provision of Electrical Services for Road Tunnels) receive the RoSPA Gold Award, and N103 (North South Corridor from Kampung Java to Suffolk) the Silver Award. Also commended by the Workplace Safety and Health Council for our participation in the WSH Influencer Programme, these accolades highlight our unwavering commitment to a culture of HSE excellence at Leighton Asia, promoting safety every day.

Source: Cimic - 10 November 2025

Novartis Opens Radioligand Therapy Plant in California to Boost Global Expansion

Novartis strengthens its leadership in radioligand therapy with the opening of a new 10,000 square foot facility in Carlsbad, California: a key milestone in its $23 billion investment in US infrastructure, ensuring increased production to meet the growing demand for precision cancer treatments, while planning new sites in Florida and Texas to transform access to innovative care. This expansion, the third site in the US, guarantees reliable and rapid delivery to patients, enhancing the American healthcare ecosystem.

Source: Novartis, published under the title "Novartis opens new radioligand therapy manufacturing facilit..." - 10 November 2025

Bayer Innovates in Sustainable Agritech at COP30 in the Amazon

At COP30, Bayer is transforming a historic building in Belém, forging agreements with Deutsche Bank and Siemens to protect tropical forests, and launching agricultural innovations like the PRO Carbono program covering 3 million hectares—with a 50% reduced carbon footprint—and achieving 100% renewable energy in China by 2026, propelling the shift towards sustainable agriculture and a green future.

Source: Bayer, published under the title "Bayer attends the climate conference in the rainforest" - 9 November 2025

Baxdrostat: Spectacular 14 mmHg Reduction in Resistant Hypertension

Baxdrostat revolutionizes the treatment of resistant hypertension: a significant 14 mmHg reduction in average 24-hour systolic blood pressure observed in the Bax24 trial, with consistent positive effects day and night. Presented at the American Heart Association Scientific Sessions 2025, this drug offers an exemplary safety profile, promising a major breakthrough for millions of patients whose blood pressure remains uncontrolled despite current therapies. Experts like Dr. Bryan Williams highlight its transformative potential to reduce cardiovascular risks.

Source: Astrazeneca, published under the title "Baxdrostat demonstrated a statistically significant and high..." - 8 November 2025

Flavors & Fragrances

TBR Showcases Olfactory Innovation at Household Summit 2025

At the Household Summit 2025 in São Paulo, TBR unveiled olfactory innovations under the theme "Emotional Memory," introducing six fragrances for household products. The event brought together industry experts to discuss technological advancements, sustainability, and emerging trends, highlighting the significance of scents in the user experience.

Source: Takasago, published under the title "Takasago Fragrâncias E Aromas Ltda. (TBR) participated House..." - 7 November 2025

GSK Unveils Major Advances in Liver Diseases at AASLD 2025

GSK presents 21 innovative abstracts on liver disease treatments, leveraging its expertise in inflammation and fibrosis. Promising results from the B-Sure study show a durable functional cure for chronic hepatitis B with bepirovirsen and Peg-IFN, while efimosfermin, administered monthly, improves fibrosis and resolves NASH, paving the way for phase III trials. Liver diseases, responsible for one in 25 deaths worldwide, are finally finding essential therapeutic answers.

Source: Gsk, published under the title "GSK presents data from its advancing liver pipeline at AASLD..." - 7 November 2025

Dupixent Achieves Success Against Allergic Fungal Rhinosinusitis: FDA Prioritizes Review

Sanofi and Regeneron's Dupixent: A Major Breakthrough Against Allergic Fungal Rhinosinusitis. The phase 3 study reveals an impressive reduction in symptoms such as sinus opacification, nasal congestion, and polyps, with a sBLA accepted for priority review by the FDA, aiming for approval in February 2026. If validated, this would be the ninth indication for this innovative treatment of chronic inflammatory diseases. A key step in improving patients' quality of life.

Source: Sanofi, published under the title "Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivota..." - 6 November 2025

DARZALEX FASPRO®: First Approved Therapy for High-Risk Smoldering Myeloma

DARZALEX FASPRO® revolutionizes the treatment of smoldering multiple myeloma: the phase 3 AQUILA study shows a 51% reduction in the risk of progression to active disease or death compared to simple active surveillance. A major breakthrough for early intervention in high-risk patients.

Source: J&j, published under the title "DARZALEX FASPRO® is the first and only treatment approved by..." - 6 November 2025

CAPLYTA®: New Therapy Approved for Major Depressive Disorder

The FDA has approved CAPLYTA® as an adjunct treatment for major depressive disorder, providing an effective and well-tolerated option. Clinical trial results show significant improvement in symptoms, with a low risk of side effects. This advancement could redefine treatment expectations for depression, offering hope for remission to millions of patients.

Source: J&j - 6 November 2025

ADM Celebrates 94 Years of Uninterrupted Dividends in Agritech

ADM celebrates 94 years of innovation in agritech: a dividend of 51 cents per share announced for its 376th consecutive quarterly payment! As a global leader in agricultural supply chains and bio-solutions, ADM reinforces its reliability, supporting food security and sustainability while connecting local needs to global capabilities. Discover how this pioneering company is transforming the future of plant technologies. To learn more, visit adm.com.

Source: Adm, published under the title "ADM Declares Cash Dividend" - 6 November 2025

Nathan Weldon-Bowen: An Indigenous Leader Championing Inclusion at UGL

UGL celebrates Nathan Weldon-Bowen, winner of the Indigenous Employee of the Year award! From his beginnings in Australian football to his key role in construction management, he leads inspiring initiatives for the inclusion of Indigenous and Torres Strait Islander communities. His journey, marked by a family legacy of leadership and advocacy, strengthens UGL's commitment to respect and equality, encouraging young Indigenous professionals to dare and assert themselves. A story of determination and positive impact on the industry and communities.

Source: Cimic - 6 November 2025

Leighton Asia Recognized for Commitment to Safety in Hong Kong

A shining pride for the Hong Kong teams! Leighton Asia triumphs at the HKCA Construction Safety Awards, winning the Proactive Safety Contractor Award for Leighton Contractors (Asia) Ltd and its partners, as well as the Safe Person-in-Charge and Safe Supervisor Awards for talents like Perry Yeung and Seto Choi Leung. These honors celebrate our unwavering HSE culture, promoting safety excellence in the construction sector.

Source: Cimic - 6 November 2025